Search

Displaying results 8891 - 8900 of 10000 in total
  1. Drug

    LGH-447

    go.drugbank.com/drugs/DB14943
    Investigational

    LGH-447 is under investigation in clinical trial NCT02160951 (Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies).

  2. Drug

    18-methoxycoronaridine

    go.drugbank.com/drugs/DB15096
    Investigational

    18-methoxycoronaridine is under investigation in clinical trial NCT03084952 (Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients).

  3. Drug

    Somatropin pegol

    go.drugbank.com/drugs/DB15112
    Investigational

    Somatropin pegol is under investigation in clinical trial NCT00715689 (Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083).

  4. Drug

    Tomuzotuximab

    go.drugbank.com/drugs/DB15178
    Investigational

    Tomuzotuximab is under investigation in clinical trial NCT02052960 (CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer).

  5. Drug

    Duvortuxizumab

    go.drugbank.com/drugs/DB15211
    Investigational

    Duvortuxizumab is under investigation in clinical trial NCT02743546 (Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma).

  6. Drug

    Ravoxertinib

    go.drugbank.com/drugs/DB15281
    Investigational

    Ravoxertinib is under investigation in clinical trial NCT01875705 (A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors).

  7. Drug

    Naratuximab emtansine

    go.drugbank.com/drugs/DB15453
    Investigational

    Naratuximab emtansine is under investigation in clinical trial NCT01534715 (IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia).

  8. Drug

    BI 2536

    go.drugbank.com/drugs/DB16107
    Investigational

    BI 2536 is under investigation in clinical trial NCT00376623 (Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer).

  9. Drug

    Otlertuzumab

    go.drugbank.com/drugs/DB16275
    Investigational

    Otlertuzumab is under investigation in clinical trial NCT01188681 (Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia).

  10. Drug

    Pelcitoclax

    go.drugbank.com/drugs/DB16285
    Investigational

    Pelcitoclax is under investigation in clinical trial NCT04210037 (Study of Combination APG-1252 Plus Paclitaxel in Patients With Relapsed/refractory Small Cell Lung Cancer).